Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Customized |
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Erdosteine is a mucolytic. Specifically it is a thiol derivative developed for the treatment of chronic obstructive bronchitis, including acute infective exacerbation of chronic bronchitis. Erdosteine contains two blocked sulfhydryl groups which are released following first-pass metabolism. The three active metabolites exhibit mucolytic and free radical scavenging activity. Erdosteine modulates mucus production and viscosity and increases mucociliary transport, thereby improving expectoration. It also exhibits inhibitory activity against the effects of free radicals produced by cigarette smoke.
Application:
Reduced mucus production: Erdosteine helps to reduce mucus production in the airways, which can alleviate symptoms like coughing and wheezing.
1.Improved lung function: By reducing mucus production and making it easier to breathe, erdosteine can also help to improve lung function in people with respiratory conditions.
2.Fewer exacerbations
Analysi | Specifications | Result |
Assay | ≥99% | 99.2% |
Appearance | White powder | Complies |
Loss on Drying | ≤1.0% | 0.04% |
Ash | ≤1.0% | 0.1% |
As | ≤2.0ppm | <2.0ppm |
Pb | ≤2.0ppm | <2.0ppm |
Insoluble impurity content | ≤0.05% | Complies |
Total Plate Count | ≤1000 cfu/g | Complies |
Yeast &. Mold | ≤100 cfu/g | Complies |
E.Coli | Negative | Negative |
Salmonella | Negative | Negative |
Conclusion |
Conform USP Standard.
|
|
Storage condition |
Store in cool & dry place, Keep away from strong light and heat.
|
|
Shelf life |
2 years when properly stored.
|